4//SEC Filing
Horn Howard 4
Accession 0000950170-25-036056
CIK 0001515673other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 12:53 PM ET
Size
5.3 KB
Accession
0000950170-25-036056
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-06$40.40/sh−1,785$72,114→ 106,169 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.73 to $41.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001786335
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 12:53 PM ET
- Size
- 5.3 KB